OVERVIEW
The market size for hematology products is expected to hit USD 5.4 billion by 2024, growing over the forecast period at a CAGR of 7.62%. Market growth is driven by factors such as increases in blood donations, increased incidence of blood disorder, and technological advances in hematology analyzers and reagents.
TABLE OF CONTENT
1 Global Hematology Analyzers and Reagents Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Hematology Analyzers and Reagents Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Hematology Analyzers and Reagents Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Hematology Analyzers and Reagents Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Hematology Analyzers and Reagents Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Hematology Analyzers and Reagents Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Hematology Analyzers and Reagents Market – By Type (Market Size – &
million/billion)
8.1 Hematology Products & Services
8.1.1 Instruments
8.1.2 Reagents & Consumables
8.1.3 Services
8.2 Hemostasis Products & Services
8.2.1 Instruments
8.2.2 Reagents & Consumables
8.2.3 Services
8.3 Immunohematology Products & Services
8.3.1 Instruments
8.3.2 Reagents & Consumables
8.3.3 Services
9 Global Hematology Analyzers and Reagents Market – By Price Range
9.1 High-End Hematology Analyzers
9.2 Mid-Range Hematology Analyzers
9.3 Low-End Hematology Analyzers
10 Global Hematology Analyzers and Reagents Market – By End-User
10.1 Hospital Laboratories
10.2 Commercial Service Providers
10.3 Government Reference Laboratories
10.4 Research and Academic Institutes
11 Global Hematology Analyzers and Reagents Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Hematology Analyzers and Reagents Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Hematology Analyzers and Reagents Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Abbott
13.3 Bio-Rad Laboratories
13.4 BioSystems (A Part of Ginper Group)
13.5 Boule
13.6 HORIBA
13.7 Mindray
13.8 Danaher
13.9 Drew Scientific
13.10 EKF Diagnostics
13.11 Diatron
13.12 Company 11 & more
14 Global Hematology Analyzers and Reagents Market – Appendix
14.1 Sources
14.2 Abbreviations